REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Supra-Biotec S.A.S. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Supra-Biotec S.A.S. Profile Updated: March 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Supra-Biotec S.A.S. is based in Ecuador, with the head office in Quito. The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on April 12, 2021. 4 (2024) employees currently work for Supra-Biotec S.A.S.. In 2025, the company reported a net sales revenue increase of 54.7%. Its’ total assets recorded a growth of 6083.53%.

Headquarters
Calle Republica del Salvador, N35-182
Quito; Pichincha;

Contact Details: Purchase the Supra-Biotec S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Supra-Biotec S.A.S. report to view the information.
Registered Capital:
Purchase the Supra-Biotec S.A.S. report to view the information.
Financial Auditors:
Purchase the Supra-Biotec S.A.S. report to view the information.
Incorporation Date:
April 12, 2021
Key Executives
Purchase this report to view the information.
Administrative Manager
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
40%
Purchase this report to view the information.
20%
Purchase this report to view the information.
20%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Supra-Biotec S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
54.7%▲
Total Operating Revenue
54.7%▲
Operating Profit
N/A
EBITDA
N/A
Net Profit/Loss for the Period
N/A
Total Assets
6083.53%▲
Total Equity
34.13%▲
Operating Profit Margin
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
0.42%▲
Cash Ratio
0.17%▲

Similar companies

Quifatex Sa
 
Laboratorios Siegfried S.A.
Roche Ecuador S.A.
 
Bayer S.A.
Nefrocontrol S.A.
 
Novartis Ecuador S.A.
Innovispharma Cia. Ltda
 
Corporacion Inova S.A.
Comercializacion Produccion y Maquila de Medicamentos y Alimentos Copromaqpharma S.A.
 
Dasmifar S.A.S.
Tibet Services S.A.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo